Table 1.
Demographic details at recruitment
| EVLA | UGFS | Surgery | |
|---|---|---|---|
| (n = 210) | (n = 286) | (n = 289) | |
| Age (years)* | 49·7 (18–80) | 49·0 (19–78) | 49·2 (22–85) |
| Sex ratio (F : M) | 120 : 90 | 162 : 124 | 163 : 126 |
| Body mass index (kg/m2)* | 27·0 (17–42) | 27·1 (17–44) | 27·7 (17–44) |
| Unilateral disease | 153 (72·9) | 215 (75·2) | 196 (67·8) |
| Employment status | |||
| Self‐employed | 21 (10·2) | 37 (13·0) | 29 (10·3) |
| Employed | 120 (58·3) | 169 (59·3) | 179 (63·5) |
| Other | 65 (31·6) | 79 (27·7) | 74 (26·2) |
| Unknown | 4 | 1 | 7 |
| Saphenous vein involvement | |||
| Great saphenous | 182 (86·7) | 232 (81·1) | 239 (82·7) |
| Small saphenous | 14 (6·7) | 21 (7·3) | 21 (7·3) |
| Great and small saphenous | 14 (6·7) | 33 (11·5) | 29 (10·0) |
| Deep vein reflux | 28 of 205 (13·7) | 47 of 280 (16·8) | 25 of 282 (8·9) |
| CEAP classification | |||
| C2, varicose veins over 3 mm | 113 (54·1) | 169 (59·1) | 147 (51·2) |
| C3, oedema | 28 (13·4) | 35 (12·2) | 39 (13·6) |
| C4, skin/subcutaneous changes | 56 (26·8) | 74 (25·9) | 90 (31·4) |
| C5/C6, healed/active venous ulcer | 12 (5·7) | 8 (2·8) | 11 (3·8) |
| Unknown | 1 | 0 | 2 |
Values in parentheses are percentages unless indicated otherwise;
*
values are mean (range). EVLA, endovenous laser ablation; UGFS, ultrasound‐guided foam sclerotherapy; CEAP, Clinical Etiologic Anatomic Pathophysiologic.